Literature DB >> 24660846

On the origin of C₆₀ fullerene solubility in aqueous solution.

Yu I Prylutskyy1, V I Petrenko, O I Ivankov, O A Kyzyma, L A Bulavin, O O Litsis, M P Evstigneev, V V Cherepanov, A G Naumovets, U Ritter.   

Abstract

In this work, we report that the surface hydroxylation of C60 molecules is the most likely mechanism for pristine C60 fullerenes/C60 fullerene aggregate stabilization in water, being independent of the method of C60 fullerene aqueous solution preparation.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24660846     DOI： 10.1021/la404976k

Source DB:  PubMed          Journal:  Langmuir        ISSN： 0743-7463            Impact factor:   3.882


  12 in total

1.  C60 fullerene affects elastic properties and osmoregulation reactions of human lymphocytes.

Authors:  Marina Yu Skorkina; Evgenia A Sladkova; Elena A Shamray; Olga V Cherkashina; Maxim P Evstigneev; Anatoly S Buchelnikov; Yuriy I Prylutskyy; Uwe Ritter
Journal:  Eur Biophys J       Date:  2015-06-14       Impact factor: 1.733

2.  Protective effect of reduced glutathione C60 derivative against hydrogen peroxide-induced apoptosis in HEK 293T cells.

Authors:  Jin Huang; Chi Zhou; Jun He; Zheng Hu; Wen-Chao Guan; Sheng-Hong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

3.  C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.

Authors:  Svitlana Prylutska; Iryna Grynyuk; Olga Matyshevska; Yuriy Prylutskyy; Maxim Evstigneev; Peter Scharff; Uwe Ritter
Journal:  Drugs R D       Date:  2014-12

4.  Complex of C60 Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy.

Authors:  Svitlana V Prylutska; Larysa M Skivka; Gennadiy V Didenko; Yuriy I Prylutskyy; Maxim P Evstigneev; Grygoriy P Potebnya; Rostyslav R Panchuk; Rostyslav S Stoika; Uwe Ritter; Peter Scharff
Journal:  Nanoscale Res Lett       Date:  2015-12-29       Impact factor: 4.703

5.  Structural Transformation of Biochar Black Carbon by C60 Superstructure: Environmental Implications.

Authors:  Minori Uchimiya; Joseph J Pignatello; Jason C White; Szu-Tung Hu; Paulo J Ferreira
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

6.  Cytotoxic Effects of Dimorfolido-N-Trichloroacetylphosphorylamide and Dimorfolido-N-Benzoylphosphorylamide in Combination with C60 Fullerene on Leukemic Cells and Docking Study of Their Interaction with DNA.

Authors:  S Prylutska; I Grynyuk; A Grebinyk; V Hurmach; Iu Shatrava; T Sliva; V Amirkhanov; Yu Prylutskyy; O Matyshevska; M Slobodyanik; M Frohme; U Ritter
Journal:  Nanoscale Res Lett       Date:  2017-02-17       Impact factor: 4.703

7.  C60 fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue.

Authors:  Yurij I Prylutskyy; Inna V Vereshchaka; Andriy V Maznychenko; Nataliya V Bulgakova; Olga O Gonchar; Olena A Kyzyma; Uwe Ritter; Peter Scharff; Tomasz Tomiak; Dmytro M Nozdrenko; Iryna V Mishchenko; Alexander I Kostyukov
Journal:  J Nanobiotechnology       Date:  2017-01-13       Impact factor: 10.435

8.  Comparative Analysis of the Antineoplastic Activity of C60 Fullerene with 5-Fluorouracil and Pyrrole Derivative In Vivo.

Authors:  O V Lynchak; Yu I Prylutskyy; V K Rybalchenko; O A Kyzyma; D Soloviov; V V Kostjukov; M P Evstigneev; U Ritter; P Scharff
Journal:  Nanoscale Res Lett       Date:  2017-01-05       Impact factor: 4.703

9.  C60 fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes.

Authors:  Larysa M Skivka; Svitlana V Prylutska; Mariia P Rudyk; Nataliia M Khranovska; Ievgeniia V Opeida; Vasyl V Hurmach; Yuriy I Prylutskyy; Leonid F Sukhodub; Uwe Ritter
Journal:  Cancer Nanotechnol       Date:  2018-10-31

10.  Antioxidant Potential of Aqueous Dispersions of Fullerenes C60, C70, and Gd@C82.

Authors:  Ivan V Mikheev; Madina M Sozarukova; Dmitry Yu Izmailov; Ivan E Kareev; Elena V Proskurnina; Mikhail A Proskurnin
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.